Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

The discovery could help ... Mar. 27, 2025 — In vertebrates, the skeleton of different regions of the body arises from different precursor cells. Researchers have now discovered that these ...

HP is an American multinational information technology corporation headquartered in Palo Alto, California, United States. It specializes in developing and manufacturing computing, data storage, and ...